Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Corporate Senior Vice President, Business Development, Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Ioannis Sapountzis has over 16 years experience in the pharmaceutical industry with specific expertise in drug discovery and business development in Oncology. Ioannis is currently serving as the Corporate Senior Vice President of Business Development & Licensing at Boehringer Ingelheim Pharmaceuticals, Inc.
Previously, he was the Global Head of BD&L USA and Specialty Care as well as Boehringer’s Global Head of Oncology Business Development & Licensing. Ioannis joined Boehringer Ingelheim in 2005 as a medicinal chemist and project leader in the Oncology therapeutic area, and later transitioned to strategic roles in the Corporate Department of Research Networking.
Ioannis holds a PhD in organic chemistry from the Ludwig Maximilians University in Munich, Germany, and did his postdoctoral fellowship with David Evans at Harvard University working on total synthesis of antibiotics.